Does Weight Gain Associated with Thiazolidinedione Use Negatively Affect Cardiometabolic Health?
Thiazolidinediones (TZDs) are oral anti-diabetic drugs that are peroxisome proliferator-activated receptor gamma (PPARγ) agonists and act as insulin sensitizers. The clinical efficacy and durability of the currently available TZDs in improving glycemic control are well established. However, TZDs cau...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Society for the Study of Obesity
2017-06-01
|
| Edice: | Journal of Obesity & Metabolic Syndrome |
| Témata: | |
| On-line přístup: | https://doi.org/10.7570/jomes.2017.26.2.102 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|